BridgeBio Pharma (BBIO) Payables (2018 - 2026)
BridgeBio Pharma (BBIO) recorded Payables of $27.2 million in Q2 2026, up 4.1% from $26.13 million a year earlier but down 6.4% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Payables (2018 - 2026) Analysis & Trends
At the end of FY2025, BridgeBio Pharma reported Payables of $36.23 million, up 276.7% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
- Across earlier years, Payables came in at $9.62 million in FY2024 (-9.7%), $10.66 million in FY2023 (-7.8%), $11.56 million in FY2022 (-2.7%) and $11.88 million in FY2021 (+32.9%).
- Quarterly Payables has ranged from $3.87 million in Q2 2023 to $36.23 million in Q4 2025 over the past five years.
- On a year-over-year basis, Payables has increased for six consecutive quarters, with growth averaging 130.2% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 482.2% in Q1 2025, against a decline of 60.6% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $29.06 million (Q1 2026), $36.23 million (Q4 2025) and $18.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn | 27.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.20 Mn |
| Mar 31, 2026 | 29.06 Mn |
| Dec 31, 2025 | 36.23 Mn |
| Sep 30, 2025 | 18.70 Mn |
| Jun 30, 2025 | 26.13 Mn |
| Mar 31, 2025 | 27.53 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 13.36 Mn |
| Jun 30, 2024 | 18.13 Mn |
| Mar 31, 2024 | 4.73 Mn |
| Dec 31, 2023 | 10.66 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 4.08 Mn |
| Dec 31, 2022 | 11.56 Mn |
| Sep 30, 2022 | 10.16 Mn |
| Jun 30, 2022 | 8.79 Mn |
| Mar 31, 2022 | 10.11 Mn |
| Dec 31, 2021 | 11.88 Mn |
| Sep 30, 2021 | 12.04 Mn |
API Access
BridgeBio Pharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();